Strategic Considerations for Cell Therapy Manufacturing Scale Up and Supply Chain
Summary:
This webinar addresses key challenges in the development, manufacturing and supply chain logistics for autologous and allogeneic cell therapies. After viewing this session, participants will have a better understanding of:
- How to identify key development and manufacturing challenges
- Commercial scalability strategies for late-stage cell therapies
- Ways to drive innovation to accelerate the delivery of cell therapies to patients faster
- How, when and why to leverage state-of-the-art facilities
- The importance of end-to-end supply chain management
Presenters:
Maria Lopez, General Manager, Catalent Princeton
Trish Demko, Director, Case Management, Catalent